{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:27:22Z","timestamp":1784723242591,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11684-024-1077-3","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T12:02:39Z","timestamp":1729512159000},"page":"1068-1086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The novel anthraquinone compound Kanglexin prevents endothelial-to-mesenchymal transition in atherosclerosis by activating FGFR1 and suppressing integrin \u03b21\/TGF\u03b2 signaling"],"prefix":"10.1007","volume":"18","author":[{"given":"Yixiu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"issue":"7855","key":"1077_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature 2021; 592(7855): 524\u2013533","journal-title":"Nature"},{"issue":"23","key":"1077_CR2","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.jacc.2020.10.029","volume":"76","author":"JR Burnett","year":"2020","unstructured":"Burnett JR, Hooper AJ, Hegele RA. Remnant cholesterol and atherosclerotic cardiovascular disease risk. J Am Coll Cardiol 2020; 76(23): 2736\u20132739","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1077_CR3","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1161\/CIRCRESAHA.120.315930","volume":"126","author":"JJ Man","year":"2020","unstructured":"Man JJ, Beckman JA, Jaffe IZ. Sex as a biological variable in atherosclerosis. Circ Res 2020; 126(9): 1297\u20131319","journal-title":"Circ Res"},{"issue":"4","key":"1077_CR4","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1002\/cphy.c210040","volume":"12","author":"DR King","year":"2022","unstructured":"King DR, Sedovy MW, Eaton X, Dunaway LS, Good ME, Isakson BE, Johnstone SR. Cell-to-cell communication in the resistance vasculature. Compr Physiol 2022; 12(4): 3833\u20133867","journal-title":"Compr Physiol"},{"issue":"2","key":"1077_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11684-022-0931-4","volume":"17","author":"Y Fan","year":"2023","unstructured":"Fan Y, Zhang Y, Zhao H, Liu W, Xu W, Jiang L, Xu R, Zheng Y, Tang X, Li X, Zhao L, Liu X, Hong Y, Lin Y, Chen H, Zhang Y. lncR-GAS5 upregulates the splicing factor SRSF10 to impair endothelial autophagy, leading to atherogenesis. Front Med 2023; 17(2): 317\u2013329","journal-title":"Front Med"},{"issue":"11","key":"1077_CR6","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/CIRCRESAHA.121.320694","volume":"130","author":"G Liang","year":"2022","unstructured":"Liang G, Wang S, Shao J, Jin YJ, Xu L, Yan Y, G\u00fcnther S, Wang L, Offermanns S. Tenascin-X mediates flow-induced suppression of EndMT and atherosclerosis. Circ Res 2022; 130(11): 1647\u20131659","journal-title":"Circ Res"},{"key":"1077_CR7","doi-asserted-by":"publisher","first-page":"734550","DOI":"10.3389\/fcvm.2021.734550","volume":"8","author":"Q Huang","year":"2021","unstructured":"Huang Q, Gan Y, Yu Z, Wu H, Zhong Z. Endothelial to mesenchymal transition: an insight in atherosclerosis. Front Cardiovasc Med 2021; 8: 734550","journal-title":"Front Cardiovasc Med"},{"issue":"28","key":"1077_CR8","doi-asserted-by":"publisher","first-page":"eabg5060","DOI":"10.1126\/sciadv.abg5060","volume":"7","author":"V Mehta","year":"2021","unstructured":"Mehta V, Pang KL, Givens CS, Chen Z, Huang J, Sweet DT, Jo H, Reader JS, Tzima E. Mechanical forces regulate endothelial-to-mesenchymal transition and atherosclerosis via an Alk5-Shc mechanotransduction pathway. Sci Adv 2021; 7(28): eabg5060","journal-title":"Sci Adv"},{"issue":"21","key":"1077_CR9","doi-asserted-by":"publisher","first-page":"11607","DOI":"10.3390\/ijms222111607","volume":"22","author":"WM Ciszewski","year":"2021","unstructured":"Ciszewski WM, Wawro ME, Sacewicz-Hofman I, Sobierajska K. Cytoskeleton reorganization in EndMT\u2014the role in cancer and fibrotic diseases. Int J Mol Sci 2021; 22(21): 11607","journal-title":"Int J Mol Sci"},{"key":"1077_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-981-13-8871-2_8","volume":"1165","author":"Z Yang","year":"2019","unstructured":"Yang Z, He LJ, Sun SR. Role of endothelial cells in renal fibrosis. Adv Exp Med Biol 2019; 1165: 145\u2013163","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"1077_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41419-021-03750-4","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, He J, Wang J, Liu J, Chen Z, Deng B, Wei L, Wu H, Liang B, Li H, Huang Y, Lu L, Yang Z, Xian S, Wang L. Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy. Cell Death Dis 2021; 12(5): 470","journal-title":"Cell Death Dis"},{"issue":"12","key":"1077_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/ars.2020.8169","volume":"34","author":"A Gorelova","year":"2021","unstructured":"Gorelova A, Berman M, Al Ghouleh I. Endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Antioxid Redox Signal 2021; 34(12): 891\u2013914","journal-title":"Antioxid Redox Signal"},{"key":"1077_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fcell.2020.00747","volume":"8","author":"N Clere","year":"2020","unstructured":"Clere N, Renault S, Corre I. Endothelial-to-mesenchymal transition in cancer. Front Cell Dev Biol 2020; 8: 747","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"1077_CR14","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1002\/jcp.26801","volume":"233","author":"H Sabbineni","year":"2018","unstructured":"Sabbineni H, Verma A, Somanath PR. Isoform-specific effects of transforming growth factor \u03b2 on endothelial-to-mesenchymal transition. J Cell Physiol 2018; 233(11): 8418\u20138428","journal-title":"J Cell Physiol"},{"issue":"8","key":"1077_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41419-020-02818-x","volume":"11","author":"L Hong","year":"2020","unstructured":"Hong L, Li F, Tang C, Li L, Sun L, Li X, Zhu L. Semaphorin 7A promotes endothelial to mesenchymal transition through ATF3 mediated TGF\u03b22\/Smad signaling. Cell Death Dis 2020; 11(8): 695","journal-title":"Cell Death Dis"},{"key":"1077_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.yjmcc.2018.12.002","volume":"127","author":"S Song","year":"2019","unstructured":"Song S, Liu L, Yu Y, Zhang R, Li Y, Cao W, Xiao Y, Fang G, Li Z, Wang X, Wang Q, Zhao X, Chen L, Wang Y, Wang Q. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF\u03b2-induced endothelial-mesenchymal transition and cardiac fibrosis. J Mol Cell Cardiol 2019; 127: 83\u201396","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"1077_CR17","doi-asserted-by":"publisher","first-page":"e3000557","DOI":"10.1371\/journal.pbio.3000557","volume":"17","author":"C Hiepen","year":"2019","unstructured":"Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, Cuellar Camacho JL, Haag R, Ruppert C, Sengle G, Cavalcanti-Adam EA, Blank KG, Knaus P. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGF\u03b2 responses and altered cell mechanics. PLoS Biol 2019; 17(12): e3000557","journal-title":"PLoS Biol"},{"issue":"3","key":"1077_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/ki.2015.103","volume":"88","author":"S Shi","year":"2015","unstructured":"Shi S, Prakash Srivastava S, Kanasaki M, He J, Kitada M, Nagai T, Nitta K, Takagi S, Kanasaki K, Koya D. Interactions of DPP-4 and integrin \u03b21 influences endothelial-to-mesenchymal transition. Kidney Int 2015; 88(3): 479\u2013489","journal-title":"Kidney Int"},{"issue":"7544","key":"1077_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature14323","volume":"519","author":"P Vitorino","year":"2015","unstructured":"Vitorino P, Yeung S, Crow A, Bakke J, Smyczek T, West K, McNamara E, Eastham-Anderson J, Gould S, Harris SF, Ndubaku C, Ye W. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility. Nature 2015; 519(7544): 425\u2013430","journal-title":"Nature"},{"issue":"8","key":"1077_CR20","doi-asserted-by":"publisher","first-page":"e2965","DOI":"10.1038\/cddis.2017.353","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Shi S, Srivastava SP, Kitada M, Nagai T, Nitta K, Kohno M, Kanasaki K, Koya D. FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysylproline via induction of the MAP4K4 pathway. Cell Death Dis 2017; 8(8): e2965","journal-title":"Cell Death Dis"},{"issue":"6","key":"1077_CR21","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.celrep.2012.10.021","volume":"2","author":"PY Chen","year":"2012","unstructured":"Chen PY, Qin L, Barnes C, Charisse K, Yi T, Zhang X, Ali R, Medina PP, Yu J, Slack FJ, Anderson DG, Kotelianski V, Wang F, Tellides G, Simons M. FGF regulates TGF-\u03b2 signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep 2012; 2(6): 1684\u20131696","journal-title":"Cell Rep"},{"issue":"344","key":"1077_CR22","doi-asserted-by":"publisher","first-page":"ra90","DOI":"10.1126\/scisignal.2005504","volume":"7","author":"PY Chen","year":"2014","unstructured":"Chen PY, Qin L, Tellides G, Simons M. Fibroblast growth factor receptor 1 is a key inhibitor of TGF\u03b2 signaling in the endothelium. Sci Signal 2014; 7(344): ra90","journal-title":"Sci Signal"},{"issue":"12","key":"1077_CR23","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1172\/JCI82719","volume":"125","author":"PY Chen","year":"2015","unstructured":"Chen PY, Qin L, Baeyens N, Li G, Afolabi T, Budatha M, Tellides G, Schwartz MA, Simons M. Endothelial-to-mesenchymal transition drives atherosclerosis progression. J Clin Invest 2015; 125(12): 4514\u20134528","journal-title":"J Clin Invest"},{"issue":"5","key":"1077_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11684-019-0711-y","volume":"13","author":"XK Li","year":"2019","unstructured":"Li XK. The FGF metabolic axis. Front Med 2019; 13(5): 511\u2013530","journal-title":"Front Med"},{"key":"1077_CR25","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3389\/fphar.2019.01548","volume":"10","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhu J, Liang H, Yang S, Zhang Y, Han W, Chen C, Cao N, Aruhan, Liang P, Du X, Huang J, Wang J, Zhang Y, Yang B. Kang Le Xin reduces blood pressure through inducing endothelial-dependent vasodilation by activating the AMPK-eNOS pathway. Front Pharmacol 2020; 10: 1548","journal-title":"Front Pharmacol"},{"key":"1077_CR26","doi-asserted-by":"publisher","first-page":"110933","DOI":"10.1016\/j.biopha.2020.110933","volume":"132","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Wang X, Yang S, Song X, Sun N, Chen C, Zhang Y, Yao D, Huang J, Wang J, Zhang Y, Yang B. Kanglexin accelerates diabetic wound healing by promoting angiogenesis via FGFR1\/ERK signaling. Biomed Pharmacother 2020; 132: 110933","journal-title":"Biomed Pharmacother"},{"key":"1077_CR27","doi-asserted-by":"publisher","first-page":"110802","DOI":"10.1016\/j.biopha.2020.110802","volume":"133","author":"X Li","year":"2021","unstructured":"Li X, Hu X, Pan T, Dong L, Ding L, Wang Z, Song R, Wang X, Wang N, Zhang Y, Wang J, Yang B. Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK\/SREBP-2\/PCSK9\/LDLR signalling pathway. Biomed Pharmacother 2021; 133: 110802","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"1077_CR28","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1111\/jcmm.17356","volume":"26","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zou H, Lu H, Xiang H, Chen S. Research progress of endothelial-mesenchymal transition in diabetic kidney disease. J Cell Mol Med 2022; 26(12): 3313\u20133322","journal-title":"J Cell Mol Med"},{"issue":"2","key":"1077_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4062\/biomolther.2015.088","volume":"24","author":"Y Shu","year":"2016","unstructured":"Shu Y, Liu Y, Li X, Gao X, Zhang NN, Lv QQ, Liu J, Li Y. Aspirin-triggered resolvin D1 inhibits TGF\u03b21-induced EndMT through increasing the expression of Smad7 and is closely related to oxidative stress. Biomol Ther (Seoul) 2016; 24(2): 132\u2013139","journal-title":"Biomol Ther (Seoul)"},{"key":"1077_CR30","doi-asserted-by":"publisher","first-page":"109098","DOI":"10.1016\/j.abb.2021.109098","volume":"715","author":"X Lin","year":"2022","unstructured":"Lin X, Ouyang S, Zhi C, Li P, Tan X, Ma W, Yu J, Peng T, Chen X, Li L, Xie W. Focus on ferroptosis, pyroptosis, apoptosis and autophagy of vascular endothelial cells to the strategic targets for the treatment of atherosclerosis. Arch Biochem Biophys 2022; 715: 109098","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"1077_CR31","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1161\/CIRCRESAHA.121.319540","volume":"130","author":"M Jia","year":"2022","unstructured":"Jia M, Li Q, Guo J, Shi W, Zhu L, Huang Y, Li Y, Wang L, Ma S, Zhuang T, Wang X, Pan Q, Wei X, Qin Y, Li X, Jin J, Zhi X, Tang J, Jing Q, Li S, Jiang L, Qu L, Osto E, Zhang J, Wang X, Yu B, Meng D. Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation. Circ Res 2022; 130(7): 1038\u20131055","journal-title":"Circ Res"},{"issue":"21","key":"1077_CR32","doi-asserted-by":"publisher","first-page":"12799","DOI":"10.1111\/jcmm.15871","volume":"24","author":"B Wang","year":"2020","unstructured":"Wang B, Ge Z, Wu Y, Zha Y, Zhang X, Yan Y, Xie Y. MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2\/3-Snail signaling pathway. J Cell Mol Med 2020; 24(21): 12799\u201312812","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1077_CR33","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2353\/ajpath.2010.091183","volume":"177","author":"YC Yeh","year":"2010","unstructured":"Yeh YC, Wei WC, Wang YK, Lin SC, Sung JM, Tang MJ. Transforming growth factor-beta1 induces Smad3-dependent beta1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol 2010; 177(4): 1743\u20131754","journal-title":"Am J Pathol"},{"issue":"27","key":"1077_CR34","doi-asserted-by":"publisher","first-page":"E3872","DOI":"10.1073\/pnas.1605074113","volume":"113","author":"Y Su","year":"2016","unstructured":"Su Y, Xia W, Li J, Walz T, Humphries MJ, Vestweber D, Caba\u00f1as C, Lu C, Springer TA. Relating conformation to function in integrin \u03b15\u03b21. Proc Natl Acad Sci USA 2016; 113(27): E3872\u2013E3881","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1077_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11684-014-0317-3","volume":"8","author":"F Ye","year":"2014","unstructured":"Ye F, Snider AK, Ginsberg MH. Talin and kindlin: the one-two punch in integrin activation. Front Med 2014; 8(1): 6\u201316","journal-title":"Front Med"},{"key":"1077_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cca.2018.12.018","volume":"490","author":"YM Hao","year":"2019","unstructured":"Hao YM, Yuan HQ, Ren Z, Qu SL, Liu LS, Wei DH, Yin K, Fu M, Jiang ZS. Endothelial to mesenchymal transition in atherosclerotic vascular remodeling. Clin Chim Acta 2019; 490: 34\u201338","journal-title":"Clin Chim Acta"},{"issue":"8","key":"1077_CR37","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1161\/CIRCRESAHA.119.314813","volume":"124","author":"J Bischoff","year":"2019","unstructured":"Bischoff J. Endothelial-to-mesenchymal transition. Circ Res 2019; 124(8): 1163\u20131165","journal-title":"Circ Res"},{"issue":"11","key":"1077_CR38","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.1002\/jcp.26801","volume":"233","author":"H Sabbineni","year":"2018","unstructured":"Sabbineni H, Verma A, Somanath P. Isoform-specific effects of transforming growth factor \u03b2 on endothelial-to-mesenchymal transition. J Cell Physiol 2018; 233(11): 8418\u20138428","journal-title":"J Cell Physiol"},{"issue":"2","key":"1077_CR39","first-page":"753","volume":"42","author":"H Liu","year":"2019","unstructured":"Liu H, Zhu Y, Zhu H, Cai R, Wang KF, Song J, Wang RX, Zhou RX. Role of transforming growth factor \u03b21 in the inhibition of gastric cancer cell proliferation by melatonin in vitro and in vivo. Oncol Rep 2019; 42(2): 753\u2013762","journal-title":"Oncol Rep"},{"key":"1077_CR40","doi-asserted-by":"publisher","first-page":"145774","DOI":"10.1016\/j.gene.2021.145774","volume":"794","author":"M Panji","year":"2021","unstructured":"Panji M, Behmard V, Zare Z, Malekpour M, Nejadbiglari H, Yavari S, Nayerpour dizaj T, Safaeian A, Maleki N, Abbasi M, Abazari O, Shabanzadeh M, Khanicheragh P. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF\u03b2-induced Epithelial-to-mesenchymal transition via ROS\/Smad signaling in human cervical cancer cells. Gene 2021; 794: 145774","journal-title":"Gene"},{"issue":"1","key":"1077_CR41","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s42003-022-03994-6","volume":"5","author":"A Bertrand-Chapel","year":"2022","unstructured":"Bertrand-Chapel A, Caligaris C, Fenouil T, Savary C, Aires S, Martel S, Huched\u00e9 P, Chassot C, Chauvet V, Cardot-Ruffino V, Morel AP, Subtil F, Mohkam K, Mabrut JY, Tonon L, Viari A, Cassier P, Hervieu V, Castets M, Mauviel A, Sentis S, Bartholin L. SMAD2\/3 mediate oncogenic effects of TGF-\u03b2 in the absence of SMAD4. Commun Biol 2022; 5(1): 1068","journal-title":"Commun Biol"},{"issue":"1","key":"1077_CR42","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1038\/ncomms5602","volume":"5","author":"HC Chuang","year":"2014","unstructured":"Chuang HC, Sheu WH, Lin YT, Tsai CY, Yang CY, Cheng YJ, Huang PY, Li JP, Chiu LL, Wang X, Xie M, Schneider MD, Tan TH. HGK\/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun 2014; 5(1): 4602","journal-title":"Nat Commun"},{"issue":"10","key":"1077_CR43","doi-asserted-by":"publisher","first-page":"10976","DOI":"10.18632\/oncotarget.7686","volume":"7","author":"HC Chuang","year":"2016","unstructured":"Chuang HC, Wang JS, Lee IT, Sheu WH, Tan TH. Epigenetic regulation of HGK\/MAP4K4 in T cells of type 2 diabetes patients. Oncotarget 2016; 7(10): 10976\u201310989","journal-title":"Oncotarget"},{"issue":"1","key":"1077_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","volume":"21","author":"RJ Slack","year":"2022","unstructured":"Slack RJ, Macdonald SJF, Roper JA, Jenkins RG, Hatley RJD. Emerging therapeutic opportunities for integrin inhibitors. Nat Rev Drug Discov 2022; 21(1): 60\u201378","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1077_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"X Pang","year":"2023","unstructured":"Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, Gu Y, Zhao N, Xiang Q, Cui Y. Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Ther 2023; 8(1): 1","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"1077_CR46","doi-asserted-by":"publisher","first-page":"e141467","DOI":"10.1172\/JCI141467","volume":"131","author":"KV Woo","year":"2021","unstructured":"Woo KV, Shen IY, Weinheimer CJ, Kovacs A, Nigro J, Lin CY, Chakinala M, Byers DE, Ornitz DM. Endothelial FGF signaling is protective in hypoxia-induced pulmonary hypertension. J Clin Invest 2021; 131(17): e141467","journal-title":"J Clin Invest"},{"key":"1077_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2023.04.001","volume":"203","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Sun N, Song X, Zhu J, Wang T, Wang Z, Yu Y, Ren J, Chen H, Zhan T, Tian J, Ma C, Huang J, Wang J, Zhang Y, Yang B. A novel small molecule AdipoR2 agonist ameliorates experimental hepatic steatosis in hamsters and mice. Free Radic Biol Med 2023; 203: 69\u201385","journal-title":"Free Radic Biol Med"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-024-1077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11684-024-1077-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-024-1077-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T20:10:19Z","timestamp":1735416619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11684-024-1077-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s11684-024-1077-3","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"9 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"<b>Conflicts of interest<\/b> Yixiu Zhao, Zhiqi Wang, Jing Ren, Huan Chen, Jia Zhu, Yue Zhang, Jiangfei Zheng, Shifeng Cao, Yanxi Li, Xue Liu, Na An, Tao Ban, Baofeng Yang, and Yan Zhang declare that they have no conflict of interest. Baofeng Yang is a member of the Editorial Board of <i>Frontiers of Medicine<\/i>, who was excluded from the peer-review process and all editorial decisions related to the acceptance and publication of this article. Peer-review was handled independently by the other editors to minimise bias.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}